阅读说明：本技术 一种康复癌症的产品及其制作工艺 (Cancer-recovering product and its preparing process ) 是由 黄希 于 2021-09-01 设计创作，主要内容包括：本发明提供一种康复癌症的产品及其制作工艺,涉及癌症药品技术领域。该产品能够抑制癌细胞的产生,提高人体免疫力,进而达到康复癌症的目的。本发明还涉及一种康复癌症产品的制作工艺,该制作工艺能够提高原料的分散性,进而保证产品质量的均一性,从而获得较为稳定的疗效。同时也去除产品中的重金属、微生物等,提高其使用安全性。(The invention provides a product for recovering cancer and a preparation process thereof, relating to the technical field of cancer drugs. The product can inhibit generation of cancer cells, and improve immunity, so as to achieve the purpose of recovering cancer. The invention also relates to a preparation process of the cancer rehabilitation product, which can improve the dispersibility of the raw materials, further ensure the uniformity of the product quality and further obtain more stable curative effect. Meanwhile, heavy metals, microorganisms and the like in the product are removed, and the use safety of the product is improved.)

1. The product for recovering cancer is characterized by comprising the following raw materials in parts by weight:

25-35 parts of alpha-albumin, 15-25 parts of immunoglobulin, 25-35 parts of phosphatidylserine, 5-15 parts of phosphatidylcholine, 1-3 parts of inositol, 0.5-1.5 parts of ovomyosin, 0.5-1.5 parts of histone, 0.05-0.15 part of carotenoid, 3-5 parts of DNA polymerase, 14-16 parts of pepsin, 0.1-1 part of vitamin and 1-2 parts of trace elements.

2. The product for rehabilitating cancer according to claim 1, comprising the following raw materials in parts by weight:

30 parts of alpha-albumin, 20 parts of immunoglobulin, 28 parts of phosphatidylserine, 10 parts of phosphatidylcholine, 2 parts of inositol, 1 part of ovoglobulin, 1 part of histone, 1 part of deoxyribose protein, 0.1 part of carotenoid, 4 parts of DNA polymerase, 15 parts of pepsin, 0.6 part of vitamin and 1.3 parts of trace elements.

3. The product for rehabilitation of cancer according to claim 1, further comprising the following raw materials in parts by weight:

0.05-1.5 parts of lactoferrin, 0.05-1.5 parts of lycopene and 1-3 parts of anthocyanin.

4. The cancer healing product of claim 1, wherein the carotenoid is β -carotene.

5. The product for rehabilitating cancer according to claim 1, wherein the DNA polymerase includes DNA polymerase II and DNA polymerase III.

6. The product for rehabilitating cancer according to claim 1, wherein the vitamins include vitamin C and vitamin B, and the mass ratio of vitamin C to vitamin B is 1: 4.

7. The cancer rehabilitation product of claim 6, wherein the vitamin B comprises niacin, vitamin B1, vitamin B2, and vitamin B6.

8. The product for rehabilitation of cancer according to claim 1, wherein said trace elements comprise magnesium, calcium and zinc in a mass ratio of 2:10: 1.

9. A process for the manufacture of a cancer healing product according to any of claims 1 to 8, comprising the steps of:

removing heavy metals from the vitamins, trace elements and carotenoids, sterilizing, sieving with 15-25 meshes, and mixing for 5-10 minutes to obtain a first mixture; removing heavy metals from the ovoglobulin, the histone, the deoxyribose protein, the inositol and the DNA polymerase, sterilizing, sieving by a sieve with 15-25 meshes, and mixing for 10-20 minutes to obtain a mixture II; adding the mixture I into the mixture II, and mixing for 10-20 minutes to obtain a mixture III; and adding the rest raw materials into the mixture III, and mixing for 20-30 minutes to obtain the product for recovering the cancers.

10. The process for preparing a cancer rehabilitation product according to claim 9, wherein the concentration of ozone in the sterilization treatment is 30-60mg/m³The sterilization time is 30-60 min.

Technical Field

The invention relates to the technical field of cancer drugs, in particular to a product for recovering cancer and a preparation process thereof.

Background

Cancer, also called malignant tumor, is a localized mass formed by abnormal proliferation of cells in local tissues under the action of various tumorigenic factors. Malignant tumors can destroy the structure and function of tissues and organs, and patients may eventually die due to exhaustion of organ functions. The basic unit of cancer lesions is cancer cells, which are caused by gene mutations in normal cells. Normally, most cells of the human body can proliferate, but the proliferation is limited, and the proliferation of cancer cells is endless, so that the nutrients of the physical energy of the patient are greatly consumed. Meanwhile, cancer cells can release various toxins, so that a series of symptoms are produced by a human body. If the cancer cells are found to be untimely and treated, the cancer cells can be transferred to all parts of the body to grow and reproduce, so that the body is thin, weak, anemia, inappetence, fever, seriously damaged organ functions and the like are caused, and severe patients can have symptoms of body weakness, pain or numbness of feet and limbs, reduction of meal, dry mouth, rough tongue, constipation and the like, so that the patients have no pain and the like. Therefore, the development of a product for recovering cancer is very important.

Disclosure of Invention

The invention aims to provide a product for recovering cancer, which can inhibit the generation of cancer cells, improve the immunity of a human body and further achieve the aim of recovering the cancer.

The invention also aims to provide a preparation process of the cancer rehabilitation product, which can improve the dispersibility of the raw materials, further ensure the uniformity of the product quality and further obtain more stable curative effect.

The technical problem to be solved by the invention is realized by adopting the following technical scheme.

The invention provides a cancer rehabilitation product, which comprises the following raw materials in parts by weight: 25-35 parts of alpha-albumin, 15-25 parts of immunoglobulin, 25-35 parts of phosphatidylserine, 5-15 parts of phosphatidylcholine, 1-3 parts of inositol, 0.5-1.5 parts of ovomyosin, 0.5-1.5 parts of histone, 0.05-0.15 part of carotenoid, 3-5 parts of DNA polymerase, 14-16 parts of pepsin, 0.1-1 part of vitamin and 1-2 parts of trace elements.

The invention also provides a manufacturing process of the cancer rehabilitation product, which comprises the following steps: removing heavy metals from vitamins, trace elements and carotenoid, sterilizing, sieving with 15-25 meshes, and mixing for 5-10 min to obtain a first mixture; removing heavy metals from the ovoglobulin, the histone, the deoxyribose protein, the inositol and the DNA polymerase, sterilizing, sieving by a sieve with 15-25 meshes, and mixing for 10-20 minutes to obtain a mixture II; adding the mixture I into the mixture II, and mixing for 10-20 minutes to obtain a mixture III; and adding the rest raw materials into the mixture III, and mixing for 20-30 minutes to obtain the product for recovering the cancer.

The product for recovering cancer and the preparation process thereof provided by the embodiment of the invention at least have the following beneficial effects:

on one hand, the product for rehabilitating the cancer, which is composed of the raw materials, can provide special protein materials and phosphatidylcholine, phosphatidylserine and phosphatidylethanolamine materials required by the cell division and replication cycle and the cell self-repair of the human body, ensure the normal chromosome of the human body, ensure the health of more newly born cells and reduce the generation of cancer cells. In addition, the product can also provide special protein materials and materials required by phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, inositol materials and chromosomes in the division and replication cycle of immune cells and cell self-repair, and ensure the health of newly born immune cells T cells and NK cells. Meanwhile, the cancer rehabilitation product also provides pepsin and improves the capacity of B cells for producing antibodies. And the trace elements provide magnesium ions, calcium ions and zinc ions for the T cell membrane, and the capacity of the T cell in recognizing cancer cells is improved. In addition, the cancer rehabilitation product also provides various raw materials such as G-type immunoglobulin and the like to improve the immunity of the organism, and various raw materials such as carotenoid and the like to inhibit the growth of cancer cells, and the mutual synergistic effect of the two raw materials achieves the aim of cancer rehabilitation.

On the other hand, in the preparation process of the rehabilitation cancer product, the raw materials are mixed in batches and then the raw materials of each batch are mixed together, so that the dispersion uniformity of the raw materials can be improved, and the uniformity of the quality of the rehabilitation cancer product is further ensured, thereby ensuring the curative effect of the rehabilitation cancer product. Moreover, the mixture can be subjected to heavy metal removal and sterilization treatment during each mixing, so that the medication safety of the cancer rehabilitation product is improved. And the particle sizes of the raw materials are consistent, so that the raw materials can be prevented from being classified due to overlarge particle size difference, and the medicinal stability of the recovered cancer product is improved.

Detailed Description

In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.

It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present invention will be described in detail below with reference to specific examples.

The invention provides a cancer rehabilitation product, which comprises the following raw materials in parts by weight: 25-35 parts of alpha-albumin, 15-25 parts of immunoglobulin, 25-35 parts of phosphatidylserine, 5-15 parts of phosphatidylcholine, 1-3 parts of inositol, 0.5-1.5 parts of ovomyosin, 0.5-1.5 parts of histone, 0.05-0.15 part of carotenoid, 3-5 parts of DNA polymerase, 14-16 parts of pepsin, 0.1-1 part of vitamin and 1-2 parts of trace elements.

Wherein the alpha-albumin can protect human body and inhibit the growth of tumor cells. Furthermore, α -albumin selectively depletes glutathione from cancer cells, and the rate of glutathione synthesis is related to the rate of cell proliferation, α -albumin sufficiently reduces glutathione from cancer cells to inhibit the growth and proliferation rate of cancer cells; in the case of normal cells, the alpha-albumin increases the concentration of glutathione in the cells, promotes the growth of normal cells, makes the cancer cells more susceptible to treatment by chemotherapy, and protects normal tissues from the deleterious effects of chemotherapy. Furthermore, alpha-albumin enhances the immune response by increasing glutathione levels in the tissue, thereby enhancing human immunity. In addition, the alpha-albumin plays a certain role in protecting and stabilizing the immunoglobulin, provides important nutrient substances for human bodies and avoids the occurrence of cancers caused by malnutrition of the human bodies.

Immunoglobulins are proteins, also called antibodies, which are produced in vivo in humans and higher animals after stimulation with an antigen and which specifically interact with the antigen, and are commonly found in mammalian blood, interstitial fluid, lymph fluid and exocrine fluid. The immunoglobulin has effects of neutralizing virus, sterilizing, promoting phagocytic cell in saliva to phagocytize virus, and improving human immune system. Cellular immunity is the first line of defense against cancer in humans, and plays an important role in preventing the occurrence of cancer and limiting the development thereof. When the cells in the organism are mutated or cancerated, the immune system of the organism can recognize the cells in time and destroy the cancer cells through a cellular immune mechanism so as to remove the cancer cells, thereby playing a role in resisting cancers. Furthermore, immunoglobulins can enhance humoral immunity against cancer, and since cancer cells and their products have certain antigenicity, the body generates immune response against them and then eliminates cancer cells.

In detail, the immunoglobulin in the present embodiment is a type G immunoglobulin and/or a type M immunoglobulin. Among them, the G-type immunoglobulin is the most important antibody in serum and plays a role of "prime immunity" in humoral immunity. The G-type immunoglobulin has various biological activities, such as specific combination with corresponding antigen, complement activation, opsonin activity, prevention and neutralization, and the like, can improve the immunity of an organism by taking the G-type immunoglobulin, can interact with the antigen or directly neutralize toxin to kill bacteria and viruses, participate in the immune regulation of the organism, and fulfill the aims of preventing and treating diseases. The M-type immunoglobulin is an antibody secreted by B cells, and has the highest molecular weight in the systemic circulation, and is the first antibody to be immunologically reacted with an antigen. The M-type immunoglobulin has strong sterilization, complement activation, immunoregulation and agglutination effects, and can play a role in bacteriolysis, cytolysis, virus neutralization and other immune effects by activating a complement system. Furthermore, M-immunoglobulin plays an important role in the immunity of anti-cancer cells in the body, belongs to a cytotoxic antibody, and can destroy tumor cells under the participation of a complement system, thereby achieving the aim of resisting cancer.

Phosphatidylserine can help repair brain injury, is one of main components of brain nerves, has the effects of nourishing and activating various enzymes in the brain, can delay the reduction process of neurotransmitter, and is beneficial to repair, update damaged brain cells and remove harmful substances. The phosphatidylserine and the DHA can cooperate with each other to protect the nerve 2A cells. The abundant phosphatidylserine can increase the fluidity of cell membranes and promote the development of intelligence. The phosphatidylserine and DHA can protect central nervous system and promote fetal intelligence development. Furthermore, the supplement of phosphatidylserine can increase the number of brain spurs and the fluidity of brain cell membranes and promote the metabolism of glucose in brain cells, thereby enabling the brain cells to be more active, improving the brain function and improving the senile dementia.

Inositol is a component of animal cells, and plays an important physiological role in lipid signaling, osmotic regulation, glucose and insulin metabolism, and the like. For example, in addition to its insulin mimetic properties, myo-inositol is essential for lipid metabolism, skeletal formation, skeletal muscle metabolism, reproductive performance and development of the nervous system in humans and animals. The inositol supplement can reduce inflammation, improve cell proliferation and oxidation resistance, and is beneficial to nerve conduction, prenatal bone development and postpartum bone reconstruction.

The ovovitellin has stronger resistance to pathogenic bacteria of immunity. The ovovitellin can be combined with glycoprotein on the surface of pathogenic bacteria or fungi, so as to block the entry of energy substances required by the growth of bacteria, inhibit the growth of bacteria, further enable pathogenic microorganisms to be easily phagocytized by phagocytes or discharged from bodies, and prevent and treat infectious diseases. The ovovitellin has high response to human bodies, can be quickly combined with bacteria and viruses to quickly activate complement, can be used for carrying out positive and negative regulation on the immunity of organisms to quickly cope with explosive diseases, does not produce drug resistance, and particularly has good curative effect on the explosive diseases caused by some viruses and bacteria.

Histone post-translational modification is one of the important ways of epigenetic regulation, and regulates chromatin structure and DNA template processes, including DNA replication, transcription and DNTA damage repair. Acetylation modification of lysine is a post-translational modification with the largest amount existing on histone, the acetylation modification can reduce positive charges of the modified histone, and the modified lysine can form hydrophobic acetyl, the two effects weaken the interaction between histone and DNA, so that chromatin structure becomes loose, further promoting the transcription process of gene, and histone acetylation modification can also influence DNA replication, nucleosome assembly and chromatin high-level structure. The current research on histone acetylation modification focuses on histone tails in disordered flexible states, and less research is currently conducted on acetylation modification of histone core regions.

Intercellular gap junction communication is the main pathway of signal transmission in cell populations, and can transmit growth regulation signals to regulate the normal proliferation and differentiation of cells. The intercellular junction communication is closely related to carcinogenesis, and inhibition or destruction of the intercellular junction communication function of most cancer cells is considered to be an important mechanism in the pro-carcinogenic stage. Carotenoids promote intercellular communication and activate damaged normal cells to maintain their growth. The communication of normal cells can make most cancer cells lose connection, so that the cancer cells are isolated and can not communicate with adjacent cancer cells, thereby stopping the growth of the cancer cells and effectively preventing the spread of the cancer. In detail, the carotenoid in the present example is β -carotene. The beta-carotene can protect receptors of macrophage membranes, participate in recognition of antigens, and is not lost by oxidation, so that the recognition capability of macrophages to the antigens can be improved, and tumor cells and differentiated tumor necrosis factors can be directly damaged. In addition, the beta-carotene also has the functions of enhancing the activity of lymphocytes, promoting the release of cytokines, resisting oxidation and the like, and can enhance the immune function of the organism. Moreover, the beta-carotene can inhibit the in vitro proliferation of human malignant neuroblastoma, gastric cancer and pancreatic cancer cells, and has the effects of prolonging the tumor latency, reducing the tumor incidence, inhibiting the tumor growth, prolonging the host life and the like.

The DNA polymerase adds dNTPs to the 3' -OH end of the extended DNA molecule step by step and successively according to the base pairing principle on the order of the template DNA with dNTPs as substrates at the RNA-OH end of the primer to synthesize the extended daughter strand DNA step by step. In addition, the DNA polymerase can also recognize and excise the nucleotide at the end of the unpaired DNA growth chain, has a certain proofreading function, and ensures the fidelity and accuracy of the replication process. Moreover, DNA polymerases play an important role in the repair of DNA damage. In detail, the DNA polymerase in the present embodiment is DNA polymerase II and/or DNA polymerase III.

The pepsin is a digestive protease, can catalyze the breakage of peptide bonds of phenylalanine, tyrosine, tryptophan, leucine, glutamic acid, glutamine and the like, so that macromolecular proteins are changed into smaller polypeptides, the digestion effect on the proteins is realized, and small fragments of amino acid, dipeptide and the like formed after decomposition are absorbed to be used for synthesizing new proteins or generating energy. When the medicine reaches the target site, the pepsin releases the medicine from the carrier protein, the released free medicine molecules play a role of medicine, and the pepsin can improve the action strength of the medicine, prevent the large fluctuation of the medicine action, prolong the medicine action time and the like.

The vitamins have certain anticancer effect, wherein the B vitamins participate in DNA synthesis, maintain genome stability, and have the functions of assisting DNA repair, regulating cell proliferation and death and the like, thereby playing the role of anticancer and cancer prevention. Nicotinic acid, a vitamin in the B group, is a component of the coenzyme Nicotinamide Adenine Dinucleotide (NAD) and its phosphate form NADP, and can regulate energy metabolism of cells, influence oxidative stress, and regulate various pathways for cell survival and death. Nicotinic acid is involved in various activities such as cell adhesion, polarity, migration, proliferation and differentiation regulation, and most importantly, has a dedifferentiation function on differentiated cells. In vivo studies have shown that oral administration of niacin reduces uv-induced immunosuppression, accelerates uv-irradiated human HaCaT keratinocytes and DNA repair of the skin in vitro, and reduces the incidence of skin cancer. In the embodiment of the invention, the vitamin B is vitamin B1, vitamin B2, vitamin B6 and vitamin B12. The high intake of vitamin B1 can reduce the incidence rate of rectal cancer and colon cancer; high intake of vitamin B2 can reduce the incidence of ovarian cancer; vitamin B12 and nicotinic acid can prevent carcinogens and DNA geometry and inhibit cancer cell growth; after entering the human body, vitamin B6 can become coenzyme and play an important role in the metabolism of protein; when the body is supplemented with vitamin B6 in a sufficient amount, the occurrence of bladder cancer can be effectively prevented. Vitamin C and beta-carotene have antioxidant effect, and can scavenge free radicals, prevent peroxidation, and prevent toxic substances from invading human cells. In addition, vitamin C has certain anticancer and cancer-preventing effects, can inhibit methylbenzylamine and sodium nitrite from synthesizing nitrosamine in vivo, and the nitrosamine belongs to a very strong carcinogenic substance, and can effectively reduce the occurrence of gastric cancer by inhibiting the generation of the nitrosamine. The anti-cancer effect is the greatest when the mass ratio of the vitamin C to the vitamin B is 1: 4.

The trace elements play an important role in human health, and participate in the life metabolic process as the components of enzymes, hormones, vitamins and nucleic acids. If the trace elements are deficient or unbalanced in proportion in human body, various physiological and biochemical changes can be caused, and various symptoms or diseases can appear. Among them, magnesium is important for maintaining the enzyme system and cardiac function, and lack of magnesium may distort chromosomes to cause tumors. Zinc is an activator of DNA, RNA polymerase, which is involved in the synthesis of proteins and insulin to affect its metabolism in the body; it also participates in metabolism of secretion systems such as thymus, thyroid, adrenaline, etc.; blocking cell membrane peroxidation, stabilizing cell membrane, and improving disease resistance, so cancer, cardiovascular disease, liver disease, various recurrent infections, and visual deterioration are related to zinc deficiency and content in human body. Calcium has high affinity for lipids, and can largely reduce the damage of lipids to cells and antagonize the effects of high-fat diet promoting colon cancer and breast cancer by neutralizing bile acids and fatty acids as tumor promoters. Zinc is used as an activator of enzyme and actively participates in body metabolism, and the deficiency of zinc can cause the function of T lymphocyte to be incomplete, thereby weakening the power of killing cancer cells. Therefore, in order to improve the anti-cancer effect of the body and maintain the normal running of the life activities of the body, the embodiment of the invention is added with trace elements which comprise magnesium, calcium and zinc, and the mass ratio of the magnesium, the calcium and the zinc is 2:10: 1.

When 30 parts of alpha-albumin, 20 parts of immunoglobulin, 28 parts of phosphatidylserine, 10 parts of phosphatidylcholine, 2 parts of inositol, 1 part of ovoglobulin, 1 part of histone, 1 part of deoxyribose protein, 0.1 part of carotenoid, 4 parts of DNA polymerase, 15 parts of pepsin, 0.6 part of vitamin and 1.3 parts of trace element are used, the ratio of the components is optimal, the anticancer effect is maximum and the side effect on the body is minimum.

The product for recovering cancer provided by the embodiment of the invention also comprises the following raw materials in parts by weight: 0.05-1.5 parts of lactoferrin, 0.05-1.5 parts of lycopene and 1-3 parts of anthocyanin.

Among them, the target cells and specific receptors on which lactoferrin acts are a prerequisite for lactoferrin to exert various biological functions. Lactoferrin receptors are distributed in small intestine, liver, monocytes, lymphocytes, platelets, fibroblasts, bone and brain tissues, and different kinds of receptors mediate lactoferrin to perform different biological functions. Lactoferrin can bind to iron ions which are essential for the growth of many microorganisms, and enters the human body so that the concentration of iron ions is reduced to inhibit the growth of microorganisms; lactoferrin can also destroy cell membranes, cause leakage of cell contents and death of the cell contents, and achieve the bacteriostatic effect. Lactoferrin has the ability of regulating macrophage activity and stimulating lymphocyte synthesis, is helpful for improving the function of the autoimmune system after being taken into a human body, enhancing resistance, regulating the balance of iron, endocrine and the like in the body, can achieve the aim of resisting virus by indirectly regulating the antiviral reaction of the immune system, can effectively inhibit the canceration of cells, and has the functions of resisting cancer and inhibiting cancer.

Lycopene is negatively associated with cancer risk, and has anticancer effect related to its strong free radical quenching mechanism and stimulating lymphocyte to release cancer cell inhibiting factor. Lycopene is more effective than beta-carotene in inhibiting cell growth in a variety of human cancer cell lines. Compared with carotene, lycopene can more effectively proliferate breast cancer cells and increase apoptosis. But only lycopene can disrupt cytoskeleton formation and selectively inhibit cells, thereby inhibiting cell cycle progression and ultimately cell proliferation. Moreover, lycopene can improve the immunity of the organism, on one hand, lycopene can promote T, B lymphocyte proliferation, enhance the activity of natural killer cells and further improve the immune response of the organism. The lycopene can protect phagocytes from self oxidative damage, promote proliferation of T, B lymphocytes, and has obvious promotion effect on nonspecific cellular immunity. Lycopene can also promote T lymphocyte transformation and enhance NK cell killing function, and the mechanism is to protect DNA of cells, avoid DNA replication damage in the proliferation process, promote intercellular communication and enhance intercellular interaction. On the other hand, lycopene can inhibit inflammatory factors such as tumor necrosis factor-alpha and the like by promoting interleukin secretion, and prevent the activation of NF-kB signal channels. And interleukin is an immune factor, and promotes the immune response of the organism by reducing inflammatory mediator factors.

Anthocyanins are present in many cell systems, such as liver, colon, cervical, breast, prostate, and other organ and tissue cells, as well as leukemia cells. In these cellular systems, anthocyanins have anti-toxic and anti-tumor properties, and inhibit mutations induced by environmental toxins and carcinogens by scavenging reactive oxygen species, enhancing the ability of cells to scavenge oxygen free radicals, and the like. In addition, anthocyanin can block the cell cycle of cancer cells, influence the synthesis and replication of DNA, thereby inhibiting the division and proliferation of cells, and can also induce the apoptosis of cancer cells.

The product for rehabilitation of cancer, which is composed of the raw materials, can provide special protein materials and phosphatidylcholine, phosphatidylserine and phosphatidylethanolamine materials required by cell self-repair in the cell division and replication cycle of a human body, ensure the normal chromosome of the human body, ensure the health of more newly born cells and reduce the generation of cancer cells. In addition, the product can also provide special protein materials and materials required by phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, inositol materials and chromosomes in the division and replication cycle of immune cells and cell self-repair, and ensure the health of newly born immune cells T cells and NK cells. Meanwhile, the cancer rehabilitation product also provides pepsin and improves the capacity of B cells for producing antibodies. And the trace elements provide magnesium ions, calcium ions and zinc ions for the T cell membrane, and the capacity of the T cell in recognizing cancer cells is improved. In addition, the cancer rehabilitation product also provides various raw materials such as G-type immunoglobulin and the like to improve the immunity of the organism, and various raw materials such as carotenoid and the like to inhibit the growth of cancer cells, and the mutual synergistic effect of the two raw materials achieves the aim of cancer rehabilitation.

The invention also provides a preparation process of the cancer rehabilitation product, which is characterized by comprising the following steps: removing heavy metals from vitamins, microelements and carotenoid, sterilizing, sieving with 15-25 mesh sieve, and mixing for 5-10 min to obtain a first mixture; removing heavy metals from the ovoglobulin, the histone, the deoxyribose protein, the inositol and the DNA polymerase, sterilizing, sieving by 15-25 meshes, and mixing for 10-20 minutes to obtain a mixture II; adding the mixture I into the mixture II, and mixing for 10-20 minutes to obtain a mixture III; and adding the rest raw materials into the mixture III, and mixing for 20-30 minutes to obtain the product for recovering the cancer.

In detail, the raw materials can be divided into three batches according to the content, and the raw materials of each batch are subjected to heavy metal removal and sterilization treatment, so that heavy metals and microorganisms in the product are removed, and the use safety performance of the product is improved. Furthermore, the raw materials of each batch are respectively mixed separately for the first mixing so as to improve the mixing uniformity in the later period. Adding the raw material I with low content into the ovoglobulin, the histone, the deoxyribose protein, the inositol and the DNA polymerase, mixing to obtain a mixture II, and adding the rest raw materials to obtain the product for recovering the cancers. Thus, less raw materials are added into more raw materials for mixing, the mixing uniformity can be improved, and products with uniform quality can be obtained. And the raw materials are screened by a screen mesh of 15-25 meshes, so that the particle sizes of the raw material particles are relatively consistent, and the influence on the curative effect of the raw material particles due to uneven quality caused by grading due to overlarge particle sizes is avoided.

In detail, the concentration of ozone for sterilization treatment is 30-60mg/m³The sterilization time is 30-60 min. Ozone disinfection is the effect of oxygen atoms oxidation to destroy the structure of microbial membrane, to realize the sterilization and disinfection. Unlike other bactericides, ozone reacts with the double bonds of bacterial cell wall lipids, acting on proteins and lipopolysaccharides, altering the permeability of cells, leading to bacterial death. The inactivation reaction to bacteria is quicker, and the sterilization is more thorough. In the embodiment of the invention, the concentration of ozone for sterilization treatment is 30-60mg/m³The sterilization time is 30-60 min.

In the preparation process of the cancer rehabilitation product, the raw materials are mixed in batches and then the raw materials of each batch are mixed together, so that the uniformity of the dispersion of the raw materials can be improved, and the uniformity of the quality of the cancer rehabilitation product is ensured, thereby ensuring the curative effect of the cancer rehabilitation product. Moreover, the mixture can be subjected to heavy metal removal and sterilization treatment during mixing at every time, so that the medication safety of the rehabilitation cancer product is improved, and the mixture can be treated once during mixing at every time, so that the efficiency of heavy metal removal and sterilization treatment can be improved, and the biological safety of the mixture is improved. And the particle sizes of the raw materials are consistent, so that the raw materials can be prevented from being classified due to overlarge particle size difference, and the medicinal stability of the recovered cancer product is improved.

The features and properties of the present invention are described in further detail below with reference to examples.

Example 1

The embodiment of the invention provides a product for recovering cancer, which comprises the following raw materials:

30g of alpha-albumin, 20g of immunoglobulin, 28g of phosphatidylserine, 10g of phosphatidylcholine, 2g of inositol, 1g of ovovitellin, 1g of histone, 1g of deoxyribose protein, 0.1g of beta-carotene, 4g of DNA polymerase, 15g of pepsin, 0.6g of vitamin, 1.3g of trace elements, 1g of lactoferrin, 1g of lycopene and 2g of anthocyanin.

It should be noted that: the DNA polymerase in the embodiment comprises DNA polymerase II and DNA polymerase III, and the corresponding mass ratio is 1: 1; the vitamins comprise vitamin C and vitamin B, and the mass ratio of the vitamin C to the vitamin B is 1: 4; vitamin B includes niacin, vitamin B1, vitamin B2, and vitamin B6; the trace elements comprise magnesium, calcium and zinc, and the mass ratio of the magnesium to the calcium to the zinc is 2:10: 1.

The embodiment of the invention provides a manufacturing process of the rehabilitation cancer product, which comprises the following steps:

removing heavy metals from vitamins, trace elements, carotenoid, lactoferrin and lycopene, sterilizing, sieving with a sieve of 20 meshes, and mixing for 10 minutes to obtain a first mixture; removing heavy metals from the ovoglobulin, the histone, the deoxyribose protein, the inositol, the DNA polymerase and the anthocyanin, sterilizing, sieving by a sieve with the mesh number of 20, and mixing for 10 minutes to obtain a mixture II; adding the mixture I into the mixture II, and mixing for 10 minutes to obtain a mixture III; adding the rest raw materials into the mixture III, and mixing for 20 minutes to obtain a product for recovering the cancer; the concentration of ozone for sterilization treatment is 30mg/m³The sterilization time is 45 min.

Example 2

The embodiment of the invention provides a product for recovering cancer, which comprises the following raw materials:

25g of alpha-albumin, 15g of immunoglobulin, 25g of phosphatidylserine, 5g of phosphatidylcholine, 1g of inositol, 0.5g of ovovitellin, 0.5g of histone, 0.5g of deoxyribose protein, 0.05g of carotenoid, 3g of DNA polymerase, 14g of pepsin, 0.1g of vitamin, 1g of trace element, 0.05g of lactoferrin, 0.05g of lycopene and 1g of anthocyanin.

It should be noted that: in the embodiment, the vitamins comprise vitamin C and vitamin B, and the mass ratio of the vitamin C to the vitamin B is 1: 4; the trace elements comprise magnesium, calcium and zinc, and the mass ratio of the magnesium to the calcium to the zinc is 2:10: 1.

The embodiment of the invention provides a manufacturing process of the rehabilitation cancer product, which comprises the following steps:

removing heavy metals from vitamins, trace elements, carotenoid, lactoferrin and lycopene, sterilizing, sieving with 15 meshes, and mixing for 5 minutes to obtain a first mixture; removing heavy metals from the ovoglobulin, the histone, the deoxyribose protein, the inositol, the DNA polymerase and the anthocyanin, sterilizing, sieving by a sieve with 15 meshes, and mixing for 15 minutes to obtain a mixture II; adding the mixture I into the mixture II, and mixing for 15 minutes to obtain a mixture III; adding the rest raw materials into the mixture III, and mixing for 25 min to obtain product for treating cancer, wherein the ozone concentration for sterilization is 30mg/m³The sterilization time is 30 min.

Example 3

The embodiment of the invention provides a product for recovering cancer, which comprises the following raw materials:

35g of alpha-albumin, 25g of immunoglobulin, 35g of phosphatidylserine, 15g of phosphatidylcholine, 3g of inositol, 1.5g of ovovitellin, 1.5g of histone, 1.5g of deoxyribose protein, 0.15g of beta-carotene, 5g of DNA polymerase, 16g of pepsin, 1g of vitamin, 2g of trace element, 1.5g of lactoferrin, 1.5g of lycopene and 3g of anthocyanin.

It should be noted that: the DNA polymerase in the embodiment comprises DNA polymerase II and DNA polymerase III, and the corresponding mass ratio is 1: 1; the vitamins include vitamin C and vitamin B, the mass ratio of the vitamin C to the vitamin B is 1:4, and the vitamin B includes nicotinic acid, vitamin B1, vitamin B2 and vitamin B6.

The embodiment of the invention provides a manufacturing process of the rehabilitation cancer product, which comprises the following steps:

removing heavy metals from vitamins, microelements, carotenoid, lactoferrin and lycopene, sterilizing, sieving with 15-25 meshes, and mixing for 5-10 min to obtain a first mixture; removing heavy metals from ovovitellin, histone, deoxyribose protein, inositol, DNA polymerase and anthocyanin, sterilizing, sieving with 15-25 mesh sieve, mixing with 10-Obtaining a second mixture after 20 minutes; adding the mixture I into the mixture II, and mixing for 10-20 minutes to obtain a mixture III; adding the rest raw materials into the mixture III, and mixing for 20-30 min to obtain product for treating cancer with ozone concentration of 60mg/m³The sterilization time is 60 min.

Example 4

The embodiment of the invention provides a product for recovering cancer, which comprises the following raw materials:

25-35g of alpha-albumin, 15-25g of immunoglobulin, 25-35g of phosphatidylserine, 5-15g of phosphatidylcholine, 1-3g of inositol, 0.5-1.5g of ovomyosin, 0.5-1.5g of histone, 0.5-1.5g of deoxyribose protein, 0.05-0.15g of carotenoid, 3-5g of DNA polymerase, 14-16g of pepsin, 0.1-1g of vitamin and 1-2g of trace elements.

It should be noted that: in this embodiment, the trace elements include magnesium, calcium, and zinc, and the mass ratio of magnesium, calcium, and zinc is 2:10: 1.

The embodiment of the invention provides a manufacturing process of the rehabilitation cancer product, which comprises the following steps:

removing heavy metals from vitamins, trace elements and carotenoid, sterilizing, sieving with 24 meshes, and mixing for 7 minutes to obtain a first mixture; removing heavy metals from the ovoglobulin, the histone, the deoxyribose protein, the inositol and the DNA polymerase, sterilizing, sieving by a sieve with 24 meshes, and mixing for 7 minutes to obtain a mixture II; adding the mixture I into the mixture II, and mixing for 15 minutes to obtain a mixture III; and adding the rest raw materials into the mixture III, and mixing for 28 minutes to obtain the product for recovering the cancer.

Example 5

The embodiment of the invention provides a product for recovering cancer, which comprises the following raw materials:

28g of alpha-albumin, 23g of immunoglobulin, 30g of phosphatidylserine, 9g of phosphatidylcholine, 2.5g of inositol, 1g of ovovitellin, 1.2g of histone, 1.2g of deoxyribose protein, 0.1g of carotenoid, 4g of DNA polymerase, 15g of pepsin, 0.5g of vitamin and 1.5g of trace elements.

The embodiment of the invention provides a manufacturing process of the rehabilitation cancer product, which comprises the following steps:

removing heavy metals from vitamins, trace elements and carotenoid, sterilizing, sieving with 18 meshes, and mixing for 9 minutes to obtain a first mixture; removing heavy metals from the ovoglobulin, the histone, the deoxyribose protein, the inositol and the DNA polymerase, sterilizing, sieving by 18 meshes, and mixing for 16 minutes to obtain a mixture II; adding the mixture I into the mixture II, and mixing for 16 minutes to obtain a mixture III; and adding the rest raw materials into the mixture III, and mixing for 26 minutes to obtain the product for recovering the cancer.

Effect example 1

The treatment method comprises the following steps: the treatment of cancer patients with the convalescent cancer products proposed in examples 1-5 was continued for 6 months and the patients' signs were recorded to evaluate their efficacy.

The therapeutic effect judgment standard is as follows: the curative effect is judged according to the guiding principle of clinical research of new traditional Chinese medicines. And (3) healing: the signs of symptoms disappear or substantially disappear. The effect is shown: the symptoms and physical signs are obviously improved. The method has the following advantages: the symptoms and physical signs are all improved. And (4) invalidation: the symptoms and signs are not obviously improved or even aggravated. A total of 30 patients diagnosed with cancer were randomized and the condition of 3 months before and after treatment is shown in Table 1.

TABLE 1 treatment before and after treatment

As can be seen from the data in Table 1, the medicines in examples 1 to 5 all improve the symptoms of pain, fatigue, sweating, insomnia, regurgitation, constipation, diarrhea and hemorrhage of patients, which indicates that the rehabilitation cancer product has a certain inhibiting effect on cancer cells, can obviously improve the physical signs of the patients after continuously taking for 3 months, basically disappears the symptoms after continuously taking for 6 months, and indicates that the patients are energetic, thus the treatment effect is better.

Effect example 2

Sample preparation: the 60 mice were randomly divided into a control group, a model group and an observation group, and each group had 20 mice. Culturing human bladder cancer cell line 5637 to a good state; mice of a model group and an observation group are taken, and well-grown cells are injected subcutaneously in the buttocks of the mice in a super clean bench, and 2X 106 human bladder cancer cell line 5637 cells suspended in 100 mu LPBS are injected into each mouse; the control group was injected with transitional epithelial cells from the human bladder, taking care that the needle was submerged under the skin by about 0.5cm, and after removing the needle, the puncture site was gently pressed with a cotton swab to prevent the overflow of the cellular fluids.

Treatment: mice were treated with the cancer-rehabilitating product of example 5, and the results were compared with each other by performing corresponding tests 6 months before and after the treatment.

And (4) checking results: (1) the reduction of cancer markers is shown by physical examination data such as B-ultrasonic, CT, Magnetic Resonance Imaging (MRI), gastroscope, enteroscope and the like;

(2) the mouse was tested in the same manner, and the results are shown in Table 2.

TABLE 2 patient test results before and after treatment

As can be seen from the data in Table 2, comparing the detected data before and after 6 months of treatment, the symptoms of the product are obviously improved when the mouse takes the product, and all the values are close to the normal values, which shows that the product for cancer rehabilitation provided by the invention has a certain rehabilitation effect on the cancer.

In summary, according to the product for cancer rehabilitation and the manufacturing process thereof of the embodiments of the present invention, on one hand, the product for cancer rehabilitation composed of the above raw materials can provide special protein materials and phosphatidylcholine, phosphatidylserine, and phosphatidylethanolamine materials required by the cell division and replication cycle and cell self-repair of the human body, thereby ensuring the normal chromosome of the human body, keeping more newly born cells healthy, and reducing the generation of cancer cells. In addition, the product can also provide special protein materials and materials required by phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, inositol materials and chromosomes in the division and replication cycle of immune cells and cell self-repair, and ensure the health of newly born immune cells T cells and NK cells. Meanwhile, the cancer rehabilitation product also provides pepsin and improves the capacity of B cells for producing antibodies. And the trace elements provide magnesium ions, calcium ions and zinc ions for the T cell membrane, and the capacity of the T cell in recognizing cancer cells is improved. In addition, the cancer rehabilitation product also provides various raw materials such as G-type immunoglobulin and the like to improve the immunity of the organism, and various raw materials such as carotenoid and the like to inhibit the growth of cancer cells, and the mutual synergistic effect of the two raw materials achieves the aim of cancer rehabilitation.

On the other hand, in the preparation process of the rehabilitation cancer product, the raw materials are mixed in batches and then the raw materials of each batch are mixed together, so that the dispersion uniformity of the raw materials can be improved, and the uniformity of the quality of the rehabilitation cancer product is further ensured, thereby ensuring the curative effect of the rehabilitation cancer product. Moreover, the mixture can be subjected to heavy metal removal and sterilization treatment during mixing at every time, so that the medication safety of the rehabilitation cancer product is improved, and the mixture can be treated once during mixing at every time, so that the efficiency of heavy metal removal and sterilization treatment can be improved, and the biological safety of the mixture is improved. And the particle sizes of the raw materials are consistent, so that the raw materials can be prevented from being classified due to overlarge particle size difference, and the medicinal stability of the recovered cancer product is improved.

The embodiments described above are some, but not all embodiments of the invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.